採血市場：製品、エンドユーザー、用途別-2025～2030年の世界予測

採血市場は、2023年に121億米ドルと評価され、2024年には129億1,000万米ドルに達すると予測され、CAGR 6.72%で成長し、2030年には190億9,000万米ドルに達すると予測されています。

採血市場は、診断、治療、研究目的でドナーや患者から血液サンプルを収集する体系的なプロセスを含む、幅広い範囲を包含しています。採血の重要性は、病気の診断、輸血の実施、健康状態のモニタリングにおける重要な役割にあります。その用途は病院、血液バンク、研究所、診断センターなど多岐にわたり、医療、研究機関、バイオテクノロジー企業などの重要な最終用途セグメントに貢献しています。市場成長は、慢性疾患や感染症の蔓延、採血技術の進歩、血液成分や検査に対する需要の高まりといった要因の影響を強く受けています。世界人口の高齢化と医療費の増加は市場拡大をさらに加速し、意識の高まりと政府のイニシアチブは採血のインフラ開拓をサポートします。キャピラリーサンプリングや乾燥血液スポット法のような、より安全で侵襲性の低い採血法の開発には、効率性と患者の快適性を高める可能性があります。しかし、この市場に課題がないわけではないです。厳しい規制環境、倫理的懸念、輸血に伴うリスクが大きな障壁となっています。また、新興国市場における一般市民の意識の低さと相まって、疾病トランスミッションの脅威も市場開拓の妨げとなっています。技術革新の焦点は、採血装置の自動化と精度の向上、データ管理強化のためのデジタルソリューションの統合であり、調査は汚染の最小化とドナーの安全性の最大化です。採血市場の将来は、アジア太平洋とラテンアメリカ新興市場が成長の原動力となる可能性があり、パーソナライゼーションと精密医療に傾斜しています。企業は、これらの地域での事業拡大、先進的な採血ソリューションの研究開発への投資、規制プロセスを合理化するポリシーの提唱などに戦略的に注力し、市場の複雑さを乗り越えながら成長機会を効果的に獲得する必要があります。

市場力学：急速に進化する採血市場の主要市場洞察を公開

採血市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患と生活習慣病の増加
  • 事故・外傷の増加
  • 献血と血液成分の需要
• 市場抑制要因
  • 自動化採血装置の高コスト
• 市場機会
  • 採血手技と製品の技術的進歩
  • 世界の手術件数の急増
• 市場課題
  • 低開発国における輸血に関するリスク

ポーターのファイブフォース：採血市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：採血市場における外部からの影響の把握

外部マクロ環境要因は、採血市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：採血市場における競合情勢の把握

採血市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス採血市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、採血市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：採血市場における成功への道筋を描く

採血市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患と生活習慣病の増加
    • 事故や外傷の増加
    • 献血と血液成分の需要
  • 抑制要因
    • 自動化された採血デバイスの高コスト
  • 機会
    • 採血手順と製品における技術的進歩
    • 世界中で実施される外科手術の数が急増
  • 課題
    • 発展途上国における輸血に関連するリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 採血市場：製品別

• イントロダクション
• 血液バッグ
• 採血針と注射器
• 採血チューブ
• 血液ランセット
• EDTAチューブ
• バイアル

第7章 採血市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 診断センター
• 病院

第8章 採血市場：用途別

• イントロダクション
• 診断
• 治療

第9章 南北アメリカの採血市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の採血市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの採血市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AdvaCare Pharma
• Becton, Dickinson, and Company
• Cardinal Healt
• Exelint International, Co.
• F.L. Medical SRL
• Greiner Bio-One International GmbH
• Haemonetics Corporation
• Medtronic Plc
• Nipro Medical Corporation
• QIAGEN N.V
• Retractable Technologies, Inc.
• SARSTEDT AG & Co. KG
• Shanghai Kohope Medical Devices Co., Ltd.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. BLOOD COLLECTION MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD COLLECTION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD COLLECTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD COLLECTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BLOOD COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BLOOD COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD COLLECTION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD COLLECTION MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION NEEDLES & SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD COLLECTION MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD COLLECTION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD COLLECTION MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BLOOD COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. BLOOD COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. BLOOD COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Collection Market was valued at USD 12.10 billion in 2023, expected to reach USD 12.91 billion in 2024, and is projected to grow at a CAGR of 6.72%, to USD 19.09 billion by 2030.

The blood collection market encompasses a broad scope, involving the systematic process of collecting blood samples from donors or patients for diagnostic, therapeutic, or research purposes. The essentiality of blood collection lies in its critical role in diagnosing diseases, conducting blood transfusions, and monitoring health conditions. Its application spans across hospitals, blood banks, laboratories, and diagnostic centers, contributing to critical end-use sectors like healthcare, research organizations, and biotechnology firms. Market growth is strongly influenced by factors such as the escalating prevalence of chronic and infectious diseases, advancements in blood collection technologies, and the rising demand for blood components and tests. The aging global population and increased healthcare expenditure further accelerate market expansion, while growing awareness and government initiatives support infrastructure development for blood collection. Opportunities abound in the development of safer, less invasive blood collection methods like capillary sampling or dried blood spot techniques, which could enhance efficiency and patient comfort. However, the market is not without challenges; stringent regulatory environments, ethical concerns, and risks associated with blood transfusions pose significant barriers. The threat of disease transmission, coupled with limited public awareness in developing regions, also hampers market progress. Innovations could focus on improving automation and precision in blood collection devices and integrating digital solutions for enhanced data management, while research could delve into minimizing contamination and maximizing donor safety. The future of the blood collection market is inclined towards personalization and precision medicine, with potential growth driven by emerging markets in Asia-Pacific and Latin America. Companies should strategically focus on expanding operations in these regions, investing in research and development for advanced blood collection solutions, and advocating for policies that streamline regulatory processes, to effectively capture growth opportunities while navigating the market's complexities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Collection Market

The Blood Collection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing chronic & lifestyle diseases
  • Rising number of accidents & trauma cases
  • Demand for blood donations and blood components
• Market Restraints
  • High cost of automated blood collection devices
• Market Opportunities
  • Technological advancements in blood collection procedures and products
  • Surge in number of surgical procedures carried out worldwide
• Market Challenges
  • Risks related to blood transfusion in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the Blood Collection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Collection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Collection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Collection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Collection Market

A detailed market share analysis in the Blood Collection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Collection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Collection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Collection Market

A strategic analysis of the Blood Collection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Collection Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Becton, Dickinson, and Company, Cardinal Healt, Exelint International, Co., F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Medtronic Plc, Nipro Medical Corporation, QIAGEN N.V, Retractable Technologies, Inc., SARSTEDT AG & Co. KG, Shanghai Kohope Medical Devices Co., Ltd., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Collection Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Bags, Blood Collection Needles & Syringes, Blood Collection Tubes, Blood Lancets, EDTA Tubes, and Vials.
• Based on End-User, market is studied across Blood Banks, Diagnostic Centers, and Hospitals.
• Based on Application, market is studied across Diagnostics and Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing chronic & lifestyle diseases
    • 5.1.1.2. Rising number of accidents & trauma cases
    • 5.1.1.3. Demand for blood donations and blood components
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of automated blood collection devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in blood collection procedures and products
    • 5.1.3.2. Surge in number of surgical procedures carried out worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Risks related to blood transfusion in underdeveloped countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Collection Market, by Product

• 6.1. Introduction
• 6.2. Blood Bags
• 6.3. Blood Collection Needles & Syringes
• 6.4. Blood Collection Tubes
• 6.5. Blood Lancets
• 6.6. EDTA Tubes
• 6.7. Vials

7. Blood Collection Market, by End-User

• 7.1. Introduction
• 7.2. Blood Banks
• 7.3. Diagnostic Centers
• 7.4. Hospitals

8. Blood Collection Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Treatment

9. Americas Blood Collection Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood Collection Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood Collection Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AdvaCare Pharma
• 3. Becton, Dickinson, and Company
• 4. Cardinal Healt
• 5. Exelint International, Co.
• 6. F.L. Medical SRL
• 7. Greiner Bio-One International GmbH
• 8. Haemonetics Corporation
• 9. Medtronic Plc
• 10. Nipro Medical Corporation
• 11. QIAGEN N.V
• 12. Retractable Technologies, Inc.
• 13. SARSTEDT AG & Co. KG
• 14. Shanghai Kohope Medical Devices Co., Ltd.
• 15. Terumo Corporation